Fortis brings together patients recovered from Total Knee Replacement, shares stories of hope & joy Kumar Jeetendra | October 22, 2021 Bengaluru, October 22, 2021: Fortis Hospital, Bannerghatta Road, undertook a distinctive approach to acknowledge and celebrate the journey of patients and their caregivers who have successfully recovered from Total Knee Replacement Surgery. A series of activities were held for the patients who had undergone Total Knee Replacement over the past 6 months as part of Aasha, a …
New antiviral compound blocks COVID 19 virus from entering cells: Study Kumar Jeetendra | October 13, 2021 Scientists have developed a chemical compound that they say could prevent infection from SARS-CoV-2 virus or reduce the severity of COVID-19 if given early in the course of an infection. The compound, called MM3122, interferes with a key feature of many viruses that allows them to invade human cells, according to the researchers at Washington …
Coronavirus vaccines viable against most SARS-CoV-2 variant: Study Kumar Jeetendra | October 13, 2021 COVID-19 vaccines by Moderna and Pfizer provide protection against multiple variants of the SARS-CoV-2 virus, including the highly infectious Delta variant, according to a study. The findings, published in the journal Nature on Tuesday, also show that those infected with the virus prior to vaccination exhibit a more robust immune response to all variants than …
Strengthen mental health services: WHO Kumar Jeetendra | October 9, 2021 Mumbai/New Delhi, 9 October 2021 – On the World Mental Health Day, the World Health Organization urges countries in South-East Asia Region to make health care for all a reality, by strengthening services to meet the increased needs and fill gaps exacerbated by the pandemic. “Majority of the people living with mental health problems in …
Do’s and Dont’s about Covid – 19 vaccines for Breast Cancer patients Kumar Jeetendra | October 7, 2021 October being the Breast cancer awareness month, let us understand few facts about COVID vaccination for breast cancer patients. We are all aware that the COIVD vaccines have come as a boon to fight the pandemic. There’s still a bit of hesitancy among cancer patients and worry about its after effects. COVID vaccine is a …
‘Saath-Saath’ helpline launched by Consortium of Palliative Care Organisations on World Hospice and Palliative Care Day Kumar Jeetendra | October 7, 2021 07th October 2021, Mumbai: Cipla Palliative Care, CanSupport, Pallium India and 8 other palliative care organizations announced the launch of the ‘Saath-Saath’ helpline today, in an effort to unify their actions and commitment to provide palliative care in the country. The helpline is a national free-of-cost service where patients, caregivers and healthcare providers can be …
Overproduction of tears and blocked ducts – The major cause of Eye-watering says Dr. Nita Shah Kumar Jeetendra | October 3, 2021 Tears to a certain level are vital for the eyes as it aids in keeping the eyes lubricated and removing any foreign bodies and dust particles. Dr. Nita Shah, Head – Clinical Services, Dr. Agarwals Eye Hospital Mumbai, explains the science behind the watering of the eyes. In medicine, an overflow of tears onto the face, …
US representative commends India’s choice to continue COVID-19 vaccination export Kumar Jeetendra | September 30, 2021 A top Republican senator on Tuesday welcomed India’s decision to resume the export of COVID-19 vaccines. Senator Jim Risch, ranking member of the Senate Foreign Relations Committee, also urged India to increase the production of such vaccines so that it can meet its international obligations. “I welcome the announcement by #India that it will restart …
Pfizer starts investigation of oral drug for counteraction of COVID-19 Kumar Jeetendra | September 27, 2021 Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the …
Novel antibody candidate shows powerful binding to different SARS-CoV-2 variant mutations Kumar Jeetendra | September 25, 2021 Twist Bioscience Corporation today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to diverse SARS-CoV-2 variant mutations, including strains with the E484K, N501Y, D614G, Y453F and K417N mutations in pseudovirus assays, indicating this therapeutic antibody may be effective in treating many strains of COVID-19. The Coronavirus Immunotherapy Consortium (CoVIC) is an academic-industry-non-profit …
Industrial chemical perfluorobutanoic acid less inclined to aggregate in human lungs and kidneys Kumar Jeetendra | September 25, 2021 A 2013 study by Perez et al. discovered a significant accumulation of the chemical used in industrial production, perfluorobutanoic Acid (PFBA) in the human kidneys and lungs. Researchers from the German Federal Institute for Risk Assessment (BfR) examined the results with an even more precise method for quantification. The resultwas that only one sample had …
Study recognizes master regulator behind the improvement of antibody delivering cells Kumar Jeetendra | September 24, 2021 The main regulator that controls the production of antibody-producing cells was identified in a research conducted by scientists from Weill Cornell Medicine. These findings offer new insights into the functioning in the immunity system. It also can help to understand how tissues form and how cancers are triggered. The study, which was published on September. …
